Cell line authentication and characterization test is a combination of processes designed to verify the identity of strains and to check that it is free from microbial and other cell line contaminants. It is a type of biological safety testing. Cell line authentication is an important step to ensure the reproducibility and integrity of biomedical research. The contaminants in cell cultures are bacteria, viruses, fungi, and contamination from other cell lines of different or same species. Contaminants alter the physiology and properties of cells, compromising the results of experiments.
The American Type Culture Collection (ATCC), a nonprofit organization that collects, stores, and distributes cell lines, standard reference microorganisms, and other materials for research and development, and other recognized cell banks, regularly performs authentication and quality control tests for various cell line samples used in the industry. Several methods are available for cell line authentication such as HLA typing, karyotyping, and isoenzyme analysis. However, currently the best method to authenticate human cell line is short tandem repeat (STR) profiling. It is a reliable, less expensive, and simple method that provides identification to the level of individual cell line.
Rise in geriatric population and increase in incidence of chronic diseases are projected to drive the global cell line authentication and characterization tests market. Additionally, growing need for accurate qualitative and quantitative analysis of cell line is anticipated to propel the market during the forecast period from 2017 to 2015. Moreover, increase in cell line production for production of biopharmaceuticals is expected to augment the market. Furthermore, rise in research for identification of novel biomolecule for drug discovery, growing awareness among people, and government regulations in different regions boost the growth of the global cell line authentication and characterization tests market. Growing research in the field of genetic engineering is also likely to drive the market during the forecast period. High adoption rate of new technologies and rapidly growing health care industry are the major drivers of the global cell line authentication and characterization tests market.
The global cell line authentication and characterization tests market can be segmented based on application and region. In terms of application, the market can be categorized into cellular therapy, gene therapy, stem cell products, tissue & tissue products, blood & blood products, and vaccines & therapeutics,
Geographically, the global cell line authentication and characterization tests market can be segmented into Asia Pacific, Latin America, Europe, North America, and Middle East & Africa. North America held the largest market share in 2016 due to increased government regulations, technological advancements, and growing awareness among people. Europe held the second largest market share in 2016 due to mandatory biological safety testing for identification of contaminants for biologics used in human. The market in Asia Pacific is projected to be driven by the growing biopharmaceutical industry, new product launches, increase in health care expenditure, and rise in research activities.
The cell line authentication and characterization tests market in Latin America is anticipated to grow during the forecast period owing to factors such as increase in research, surge in incidence of pandemic and endemic diseases, rise in per capita income of the middle class, technological advancements, and government regulations. The cell line authentication and characterization tests market in Middle East & Africa is projected to grow during the forecast period driven by increase in technological upgrades and enhanced participation of governments to promote academic research to improve these technologies.
Key players operating in the global cell line authentication and characterization tests market include Thermo Fisher Scientific, Inc., Charles River Laboratories International, Inc., Lonza, Takara Bio USA, Inc., GE Healthcare, and QIAGEN.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.